Mitigate risk, stay compliant, and accelerate reporting.
Sorcero delivers exponential improvements to regulatory affairs productivity with tools to capture, enrich, and analyze the content that matters most. We improve the efficiency of time-consuming tasks, from tracking literature and adverse events to reviewing post-market performance.
The regulatory affairs advantage.
Sorcero leverages advanced algorithms and disease-focused ontologies to organize and understand how language is used in Life Sciences. That means you can gain clarity with optimized post-market monitoring processes and analytics across therapeutic areas all over the world.
Collect, evaluate, and document post-market performance of key product offerings, while discovering sentiment and application of unique molecules.Read More
who we help
Magnify your potential.
Regulatory affairs is a rapidly growing segment in life sciences and absolutely critical in ensuring compliance with applicable global requirements. With a 1,000% increase in medical content management productivity and up to a 90% reduction in post-market surveillance monitoring time, transform how regulatory affairs mitigates risk.
Regulatory Affairs Liaisons (RAL)
Optimize processes and interactions with project teams and regulatory health agencies, such as the U.S. Food and Drug Administration (FDA) and the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH).
Mitigate risk by accelerating regulatory reporting, label updates, and the publication of regulatory reports to meet evolving requirements.
Regulatory Affairs Leadership
Visualize approved, in-process materials, and publications in a single, user-friendly dashboard to stay ahead of compliance risk and regulatory burden.
By The Numbers
40% of the top 10 global life sciences enterprises have experienced:
Magnify your potential.View All Resources
Sorcero Podcast Series: J&J VP of US Oncology Medical Affairs on Working at the Nexus of Medical Innovation
Here is the fifth episode in the Sorcero miniseries on building great AI-powered life sciences products, a Mighty Capital podcast.